CIMZIA® (certolizumab pegol)
is indicated for adults with:

RA

MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS (RA)

PsA

ACTIVE PSORIATIC ARTHRITIS (PsA)

AS

ACTIVE ANKYLOSING SPONDYLITIS (AS)

CD

MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE (CD) IF RESPONSE TO CONVENTIONAL THERAPY IS INADEQUATE

PSO

Moderate to severe plaque psoriasis (PSO)
who are candidates for systemic therapy or phototherapy

NR
axSpA

ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS (NR-AXSPA)
WITH OBJECTIVE SIGNS OF INFLAMMATION

Get the whole story!

CIMZIA formulation options align with patient needs.


CIMplicity®: Confidence in care

Patient support with hands-on assistance and services.